96 related articles for article (PubMed ID: 3112404)
1. The capacity of blood lymphoid cells to produce alpha- and gamma-interferon is decreased during alpha-interferon therapy.
Einhorn S; Ling P; Einhorn N; Strander H
J Clin Lab Immunol; 1987 May; 23(1):35-8. PubMed ID: 3112404
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo interferon production in NOD mice.
Tsumura H; Komada H; Ito Y; Shimura K
Lab Anim Sci; 1989 Nov; 39(6):575-8. PubMed ID: 2512417
[TBL] [Abstract][Full Text] [Related]
3. Evolution of hepatitis C virus-specific T cell responses and cytokine production in chronic hepatitis C patients treated with high doses of interferon-alpha.
Alvarado Esquivel C; Elewaut A; Philippé J; Elewaut AE; Desombere I; Maertens G; Leroux-Roels G
Rev Invest Clin; 2002; 54(1):41-50. PubMed ID: 11995406
[TBL] [Abstract][Full Text] [Related]
4. Interferon system in patients with systemic juvenile chronic arthritis: in vivo and in vitro studies.
Bacon TH; de Vere-Tyndall A; Tyrrell DA; Denman AM; Ansell BM
Clin Exp Immunol; 1983 Oct; 54(1):23-30. PubMed ID: 6413108
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of human interferon alpha and interferon gamma on xenografted human thyroid tissue in severe combined immunodeficient mice and nude mice.
Kawai K; Enomoto T; Fornasier V; Resetkova E; Volpé R
Proc Assoc Am Physicians; 1997 Mar; 109(2):126-35. PubMed ID: 9069581
[TBL] [Abstract][Full Text] [Related]
6. [T-cell interferon-gamma, tumor necrosis factor-alpha and interleukin-6 receptor binding in patients with multiple sclerosis. Effects of interferon-beta-1b treatment].
Bongioanni P; Romano MR; Boccardi B; Lombardo F; Moscato G; Mosti S; Baldini C; Nuti S; Meucci G; Rossi B
Rev Neurol; 1999 Nov 16-30; 29(10):893-9. PubMed ID: 10637835
[TBL] [Abstract][Full Text] [Related]
7. Influence of alpha-interferon therapy on blood lymphoid cells. Studies on antibody production, mixed lymphocyte culture response, mitogen responsiveness and 2'-5'oligoadenylate synthetase activity.
Einhorn S; Ling P; Einhorn N; Strander H; Wasserman J
Cancer Immunol Immunother; 1987; 24(3):190-6. PubMed ID: 2954635
[TBL] [Abstract][Full Text] [Related]
8. Interferon-gamma production by peripheral blood leucocytes from patients with multiple sclerosis and other neurological diseases.
Vervliet G; Carton H; Billiau A
Clin Exp Immunol; 1985 Feb; 59(2):391-7. PubMed ID: 3919978
[TBL] [Abstract][Full Text] [Related]
9. Interferon production by cultured peripheral leucocytes of MS patients.
Vervliet G; Carton H; Meulepas E; Billiau A
Clin Exp Immunol; 1984 Oct; 58(1):116-26. PubMed ID: 6206970
[TBL] [Abstract][Full Text] [Related]
10. Alpha interferon production in patients with hairy cell leukemia: correlations with disease activity and remission status.
Lepe-Zuniga JL; Quesada JR; Baron S; Reuben J; Gutterman JU
Hematol Pathol; 1987; 1(3):157-65. PubMed ID: 3150846
[TBL] [Abstract][Full Text] [Related]
11. Interferon-gamma production by peripheral blood mononuclear cells from patients with Behçet's syndrome.
Bacon TH; Ozbakir F; Elms CA; Denman AM
Clin Exp Immunol; 1984 Sep; 57(3):541-7. PubMed ID: 6432387
[TBL] [Abstract][Full Text] [Related]
12. Correlation of clinical and immunological parameters of metastatic renal cell carcinoma patients undergoing therapy with interleukin 2, interferon-alpha and retinoic acid.
Elsässer-Beile U; Kölble N; Grussenmeyer T; Wetterauer U; Schultze-Seemann W
Anticancer Res; 1998; 18(3B):1883-90. PubMed ID: 9677439
[TBL] [Abstract][Full Text] [Related]
13. Switching on of the proliferation or apoptosis of activated human T lymphocytes by IFN-gamma is correlated with the differential expression of the alpha- and beta-chains of its receptor.
Novelli F; Bernabei P; Ozmen L; Rigamonti L; Allione A; Pestka S; Garotta G; Forni G
J Immunol; 1996 Sep; 157(5):1935-43. PubMed ID: 8757312
[TBL] [Abstract][Full Text] [Related]
14. Increased IFN-gamma synthesis by T cells from patients on imatinib therapy for chronic myeloid leukemia.
Aswald JM; Lipton JH; Aswald S; Messner HA
Cytokines Cell Mol Ther; 2002; 7(4):143-9. PubMed ID: 14660054
[TBL] [Abstract][Full Text] [Related]
15. [Interferon-producing capacity in patients with prostate cancer: prognosis value].
Kita M; Nakagawa S; Watanabe H; Kitoh I; Yamaji M; Kishida T; Imanishi J
C R Seances Soc Biol Fil; 1990; 184(2):181-6. PubMed ID: 2148903
[TBL] [Abstract][Full Text] [Related]
16. [Interferon production in peripheral blood cells of patients with pulmonary mycobacterial disease].
Tada A; Kawahara S; Tamaoki A; Takeuchi M; Tanimoto Y; Okada C; Mishima Y; Soda R; Takahashi K; Kibata M
Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Feb; 33(2):114-9. PubMed ID: 7731113
[TBL] [Abstract][Full Text] [Related]
17. Interferon producing capacity (IPCA) of peripheral mononuclear cell in oral cancer patients.
Jamkar AV; Banerjae AC; Gore MM; Sathe PS; Ghosh SN
Indian J Cancer; 1989 Jun; 26(2):76-84. PubMed ID: 2512248
[TBL] [Abstract][Full Text] [Related]
18. [Interferon (IFN) therapy (recombinant IFN-alpha-2C or recombinant IFN-gamma) in metastasized hypernephroma].
Kuzmits R; Scheithauer W; Ludwig H; Flener R
Acta Med Austriaca; 1985; 12(5):129-34. PubMed ID: 3938590
[TBL] [Abstract][Full Text] [Related]
19. T helper 1/T helper 2 cytokine imbalance in respiratory syncytial virus infection is associated with increased endogenous plasma cortisol.
Pinto RA; Arredondo SM; Bono MR; Gaggero AA; Díaz PV
Pediatrics; 2006 May; 117(5):e878-86. PubMed ID: 16618789
[TBL] [Abstract][Full Text] [Related]
20. The synergistic effect of phytohemagglutinin and interferon-gamma on the expression of tumor necrosis factor-alpha from RAW 264.7 cells.
Chang SH; Mun SH; Ko NY; Lee JH; Jun MH; Seo JY; Kim YM; Choi WS; Her E
Immunol Lett; 2005 Apr; 98(1):137-43. PubMed ID: 15790519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
